Arrowhead Pharmaceuticals, Inc. (ARWR) Revenue Growth
Arrowhead Pharmaceuticals, Inc. (ARWR) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-09-30 | 19736.49% |
| 2018-09-30 | -48.60% |
| 2019-09-30 | 945.67% |
| 2020-09-30 | -47.87% |
| 2021-09-30 | 57.16% |
| 2022-09-30 | 75.89% |
| 2023-09-30 | -1.03% |
| 2024-09-30 | -98.52% |
| 2025-09-30 | 23258.15% |
How ARWR compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| IDYA | IDEAYA Biosciences Inc. | 3024.43% |
| SNDX | Syndax Pharmaceuticals Inc. | 627.84% |
| ETON | Eton Pharmaceuticals Inc. | 104.94% |
| BCRX | BioCryst Pharmaceuticals Inc. | 94.10% |
| TGTX | TG Therapeutics Inc. | 87.32% |
These are five companies in the same sector as ARWR with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Arrowhead Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("ARWR", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ARWR | $85.37 | +3.18% | 1.52M |
| 3 | ||||
| 4 | ||||
| 5 |